What is a typical management option for terminal-stage hepatocellular carcinoma (Stage D)?

Prepare for Liver Disease and Tumors Test with tailored flashcards and questions. Get detailed explanations and improve your knowledge. Ace the medical student exam!

In terminal-stage hepatocellular carcinoma the focus is on comfort and quality of life rather than cure. When disease is advanced with poor liver function, aiming to control the tumor is unlikely to be successful or sustainable, and the risks of aggressive treatments far outweigh the benefits. Palliative and supportive care addresses symptoms such as pain, ascites, jaundice, hepatic encephalopathy, and nutritional issues, while also supporting psychosocial and caregiver needs. Transplantation or aggressive surgical resection require good liver reserve and localized disease; in this stage these conditions are typically not feasible, since the disease burden and underlying liver failure preclude curative outcomes. High-dose systemic chemotherapy is not standard because hepatocellular carcinoma often responds poorly to conventional chemotherapy and the substantial toxicity can worsen liver function. Thus, the typical management for terminal-stage disease is palliative/supportive care aimed at comfort and quality of life.